The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
As the drugmaker moves into Phase III studies for survodutide, its new GLP-1 obesity drug, Walgreens will use its community pharmacies as clinical trial sites, aiming to improve access and address equitable health representation.
Although employees weigh a number of factors when making health plan decisions, cost remains the overriding factor, and employer contributions are the main reason why employees choose an HSA, says a new survey.
A House Committee approved the Biosecure Act to end U.S. contracting with Chinese firms deemed a threat to national security, but filling the void left by Chinese companies may be a challenge to U.S. drug development.
There is a 19 percentage point gap between employers' perceptions of employee satisfaction with their benefits and actual lived experiences, which has widened since 2021.
In the wake of the May 8 cyberattack on Ascension, which operates 140 hospitals in 19 states, two class-action lawsuits have been filed, alleging that the company failed to safeguard protected health information.
Since 2012, every state except Alabama has either enacted or introduced legislation that would establish state-facilitated retirement savings programs, and 10 states already have fully operating auto-IRAs.
At a Senate Judiciary Committee hearing, Senators accused drugmakers of gaming the system by filing 100+ patents for any given drug, while trade group PhRMA said the system advances "the development of new medicines."
The Labor Department is amending the Abandoned Plan Program, originally adopted in 2006, so trustees can distribute assets from bankrupt companies' retirement plans to workers and retirees, starting July 16, 2024.